{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/shingles/supporting-evidence/","result":{"pageContext":{"chapter":{"id":"67979756-a00f-5f10-a93e-81509b35e1a8","slug":"supporting-evidence","fullItemName":"Supporting evidence","depth":1,"htmlHeader":"<!-- begin field 044b9b45-45ac-4e97-be37-0822ae322d5b --><h1>Supporting evidence</h1><!-- end field 044b9b45-45ac-4e97-be37-0822ae322d5b -->","summary":null,"htmlStringContent":"<!-- begin item 25ba8d72-0cdd-4c8d-812c-777a90641718 --><!-- begin field 4ebd08e0-47a5-405e-973d-c4531c0d7a1b --><p>The recommendations in this CKS topic are largely based on <em>Summary of antimicrobial prescribing guidance – managing common infections (September 2019)</em> published by the National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">NICE and PHE, 2019</a>], the chapter on <em>Shingles (herpes zoster)</em> in <em>Immunisation against infectious disease</em> (the 'Green book'), published by PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">PHE, 2016</a>], the PHE guideline <em>Vaccination against shingles. Information for healthcare professionals </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">PHE, 2018</a>], the Primary Care Dermatology Society (PCDS) guideline <em>Herpes zoster (syn. shingles)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">PCDS, 2017</a>], the <em>European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Werner, 2017b</a>], and review articles.</p><ul><li>The rationales for the recommendations in this CKS topic are outlined in the relevant basis for recommendation sections of the topic.</li><li>The rationales for recommendations in the NICE and PHE antimicrobial prescribing guidance are outlined in the <a data-hyperlink-id=\"7c8b4f92-eccd-4ad1-99df-aad6014671cf\" href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/825957/Common_Infect_PHE_context_references_and_rationale_July_2019.pdf\">Summary of antimicrobial prescribing guidance – managing common infections: PHE context, references and rationales</a> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">PHE, 2019b</a>]. </li></ul><!-- end field 4ebd08e0-47a5-405e-973d-c4531c0d7a1b --><!-- end item 25ba8d72-0cdd-4c8d-812c-777a90641718 -->","topic":{"id":"012e484d-8c14-5168-bb5d-e5acb7d4571a","topicId":"2969a8ac-cb7f-4569-be79-822e6009081a","topicName":"Shingles","slug":"shingles","lastRevised":"Last revised in October 2020","chapters":[{"id":"eeb1b918-6c05-5340-b348-ce2809516623","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ad8b1b2-36bb-5262-ab5a-05763d6e4c7d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b1aed669-8481-5315-ab58-4bb18606e360","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8fef2c66-91dc-57c6-8cd3-4e4eff8d7727","slug":"changes","fullItemName":"Changes"},{"id":"ea603e45-ec07-5201-a182-ebef4c48ef6b","slug":"update","fullItemName":"Update"}]},{"id":"81feec28-1a5d-5a24-9c52-bee13821b03b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bb672f83-c2bd-5dd7-9934-78f09729db48","slug":"goals","fullItemName":"Goals"},{"id":"2036bd3f-37bc-5cea-887d-55c3fc68c7cf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cc04b460-a0d8-5e8d-b8d0-c044947b4bd6","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ee3573cb-38d5-5d4c-9c9d-cd274242d964","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"52999d3b-9cce-59c5-b588-1f7ad7de33e2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"40a91fd6-3c01-5713-85ad-0a5c4379eab9","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"04a0af22-814d-5b14-b28c-7916f1772a4d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"097dfec6-754a-54a8-9d96-44e1c5704248","slug":"definition","fullItemName":"Definition"},{"id":"f20034b1-ae3e-505b-ac16-3e11f2a6653e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e92f0243-b1ac-50d9-a31a-a07a4c61c5a7","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b6f8c581-b332-5d26-ba45-ccfb7189a387","slug":"complications","fullItemName":"Complications"},{"id":"012c8f32-e9cf-5897-a695-4c21cd28ae5d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"81f3feff-d640-5ee2-83fa-af1a4e8b586a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"56b89dcf-d466-50f3-a8a0-3a9477ef3362","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"01bc96b7-ea05-59b9-963a-16b2722b9367","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"acd9aec2-87d6-5084-bd3a-5c0b1d164ab4","fullItemName":"Management","slug":"management","subChapters":[{"id":"9872f447-6f59-502d-b6cb-a0fae6d2c085","slug":"management","fullItemName":"Scenario: Management"},{"id":"9ecdcc36-4fec-5b60-aa42-2032f2c406a4","slug":"prevention","fullItemName":"Scenario: Prevention"}]},{"id":"929d18e1-e1f0-5d08-8c55-d289b349a9fd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4445c1da-4f7a-5f12-a909-0112bbd72453","slug":"antiviral-drugs","fullItemName":"Antiviral drugs"},{"id":"1223613b-f5a6-5da6-a311-275f5d6181b2","slug":"zostavax","fullItemName":"Zostavax"}]},{"id":"67979756-a00f-5f10-a93e-81509b35e1a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"625749c2-4e09-57ba-bdee-cd206d8b02d5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"377ce207-6229-5548-aef7-a637f176a94e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"19ac0831-d4e2-52c3-b127-e78b1f26fb6f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d46d7aff-a113-50d5-afa1-3310aad844d7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d23205e9-41c9-5c70-a9f9-5ce3cfae633a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cf98894b-c083-59fd-8150-f390845960f1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a52b727c-ba28-5973-9e3c-e4882a883593","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}